Please assess the completion status of the following clinical trial:

Trial Title: Use of Post Operative Loperamide in Colorectal Patients After Diverting Ileostomies

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Able to freely give written informed consent to participate in the study and have signed the Informed Consent Form;~2. Males or females, age 18 and older at the time of study screening;~3. American Society of Anesthesiologists (ASA) Class I-III (Appendix III) undergoing elective surgery~Exclusion Criteria:~1. Mentally incompetent or unable or unwilling to provide informed consent or comply with study procedures~2. American Society of Anesthesiologists (ASA) Class IV or V; emergency surgeries~3. Children \<18~4. Pregnant patients~5. Patients who have intra-abdominal sepsis or partial or intermittent bowel obstruction or enteritis~6. Patients who are on long term steroids, opioids or antidiarrheals pre operatively~7. Patients who are administered pro kinetics eg. Metoclopramide~8. Patients with recurrent disease in their small bowel - Crohn's disease, or previous irradiated pelvis resulting in irradiation bowel disease~9. End ileostomies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): None
- Therapeutic (Type: EXPERIMENTAL): Patients randomized to this arm will be administered 4mg tid (three times daily) of loperamide from the day of discharge onwards. A total of duration of 14 days of medication will be administered

Based on this trial design, predict the completion outcome and termination type (if applicable).